```html

Yellowing of Eyes (Scleral Icterus)

What is Yellowing of Eyes (Scleral Icterus)?

Yellowing of the eyes, medically called scleral icterus, refers to a pale‑yellow discoloration of the white part of the eye (the sclera). The hue appears because bilirubin—a yellow pigment produced when red blood cells break down—accumulates in the blood and deposits in tissues with a high blood supply, such as the sclera and skin. While a slight yellow tint may be harmless in newborns, in adults it is usually a sign that something is affecting the liver, gallbladder, pancreas, or red‑cell turnover.

The change can be subtle (just a faint shade) or striking, and it often accompanies yellowing of the skin (jaundice). Because the sclera is very vascular, it can reveal modest increases in bilirubin that are not yet visible elsewhere, making scleral icterus an early visual cue for clinicians.

Common Causes

Many conditions raise bilirubin levels enough to cause scleral icterus. The most frequent are:

• Hepatitis A, B, or C – viral inflammation damages liver cells, reducing bilirubin clearance.
• Alcoholic liver disease / Alcoholic cirrhosis – chronic alcohol use leads to fatty change, hepatitis, and scarring.
• Non‑alcoholic fatty liver disease (NAFLD) and non‑alcoholic steatohepatitis (NASH) – metabolic syndrome‑related fat buildup impairs liver function.
• Bile duct obstruction (e.g., gallstones, cholangiocarcinoma, pancreatic head tumor) – blockage prevents bilirubin from reaching the intestine.
• Hemolytic anemia – rapid destruction of red blood cells releases excess bilirubin faster than the liver can process it.
• Gilbert’s syndrome – a common, benign genetic variant that reduces the liver’s ability to conjugate bilirubin.
• Medication‑induced liver injury – acetaminophen overdose, certain antibiotics, statins, or herbal supplements.
• Primary sclerosing cholangitis (PSC) – chronic inflammation and scarring of intra‑ and extra‑hepatic bile ducts.
• Pancreatic cancer – especially tumors in the pancreatic head that compress the distal bile duct.
• Sepsis or severe infection – can cause cholestasis (reduced bile flow) leading to bilirubin rise.

Associated Symptoms

Yellowing of the eyes rarely occurs in isolation. Look for these accompanying signs that may point toward the underlying cause:

• Yellowing of the skin, especially on the face, neck, and under the eyes.
• Dark urine (bilirubin in urine) and pale, clay‑colored stools.
• Pruritus (itchy skin) – common when bile salts accumulate under the skin.
• Upper‑right abdominal pain or fullness.
• Fever, chills, or flu‑like symptoms (suggestive of infectious hepatitis or cholangitis).
• Unexplained weight loss or loss of appetite.
• Fatigue and generalized weakness.
• Swelling of the abdomen (ascites) or legs (edema) in advanced liver disease.
• Bruising or easy bleeding (due to impaired clotting factor production).
• Redness or tenderness over the gallbladder (Murphy’s sign) when gallstones are present.

When to See a Doctor

Because scleral icterus can signal serious liver or blood‑cell problems, prompt evaluation is important. Seek medical care if you notice any of the following:

• Yellowing of the eyes that persists for more than a few days.
• Concurrent yellowing of the skin, dark urine, or pale stools.
• Abdominal pain, especially in the upper‑right quadrant.
• Fever, chills, or a feeling of being terribly ill.
• Sudden, severe itching or a rash.
• Unexplained weight loss, loss of appetite, or persistent fatigue.
• Bleeding easily or noticing bruises that appear without injury.
• History of liver disease, recent heavy alcohol use, or exposure to hepatitis‑risk factors.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted laboratory and imaging studies.

1. History & Physical Examination

• Duration and progression of yellowing.
• Alcohol intake, medication use, travel, and sexual history (risk for viral hepatitis).
• Family history of liver disease or genetic conditions (e.g., Gilbert’s).
• Assessment of abdomen for tenderness, liver size, and gallbladder distension.

2. Laboratory Tests

• Total and direct bilirubin – quantifies the amount and determines if bilirubin is conjugated.
• Liver enzyme panel (ALT, AST, ALP, GGT) – helps differentiate hepatocellular injury vs. cholestasis.
• Complete blood count (CBC) – looks for anemia, leukocytosis, or platelet abnormalities.
• Coagulation studies (PT/INR) – liver synthetic function.
• Viral hepatitis serologies (HBsAg, anti‑HBc, anti‑HCV).
• Autoimmune markers (ANA, SMA, anti‑LKM) when autoimmune hepatitis is suspected.

3. Imaging

• Abdominal ultrasound – first‑line to evaluate liver texture, gallstones, bile duct dilatation.
• CT or MRI abdomen – for detailed assessment of tumors, strictures, or vascular lesions.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive view of the bile ducts.

4. Specialized Tests (when indicated)

• Endoscopic retrograde cholangiopancreatography (ERCP) – diagnostic and therapeutic for ductal obstruction.
• Liver biopsy – to confirm cirrhosis, NASH, or infiltrative disease when non‑invasive tests are inconclusive.
• Hemolysis work‑up (haptoglobin, LDH, peripheral smear) – if a hemolytic anemia is suspected.

Treatment Options

Treatment is directed at the underlying cause; there is no specific “cure” for scleral icterus itself. General supportive care is also important.

1. Manage Underlying Liver Disease

• Viral hepatitis: Antiviral regimens (e.g., sofosbuvir/velpatasvir for HCV, tenofovir or entecavir for HBV).
• Alcohol‑related liver disease: Complete abstinence, nutritional support, consideration of steroids for alcoholic hepatitis, and referral to addiction services.
• NAFLD/NASH: Weight loss (7‑10% of body weight), exercise, control of diabetes and hyperlipidemia; vitamin E or pioglitazone may be used in select patients.
• Biliary obstruction: Endoscopic stone removal, stenting, or surgery to relieve the blockage.

**Medication‑induced injury** – discontinue the offending drug; in acetaminophen toxicity, administer N‑acetylcysteine promptly.

2. Treat Hemolysis

• Identify trigger (autoimmune, sickle cell, G6PD deficiency, drug‑induced) and treat accordingly.
• Transfusions for severe anemia, corticosteroids for autoimmune hemolysis, or splenectomy in chronic cases.

3. Symptomatic & Supportive Care

• Hydration and a balanced diet rich in protein and vitamins.
• Pruritus relief: cholestyramine, antihistamines, or topical emollients.
• Vitamin K supplementation if clotting factors are low.
• Monitoring for complications such as ascites, hepatic encephalopathy, or variceal bleeding.

4. Home Measures While Awaiting Care

• Avoid alcohol and hepatotoxic over‑the‑counter meds (e.g., high‑dose acetaminophen).
• Maintain a healthy weight; limit saturated fats and added sugars.
• Stay up‑to‑date on hepatitis vaccinations (A and B).
• Practice good hand hygiene to reduce infection risk, especially if cholestasis is present.

Prevention Tips

• Vaccinate against hepatitis A and B.
• Limit alcohol intake to ≤ 14 units per week for men and ≤ 7 units for women, or abstain if liver disease is present.
• Maintain a healthy weight through regular exercise (150 min moderate activity/week) and a Mediterranean‑style diet.
• Use medications wisely—follow dosing recommendations and discuss liver‑related side effects with your pharmacist or physician.
• Practice safe sex and avoid sharing needles to reduce hepatitis transmission.
• Schedule routine health checks: liver function tests if you have risk factors (e.g., diabetes, obesity, family history).
• Stay hydrated and limit consumption of high‑fructose corn syrup and trans fats, which can worsen NAFLD.
• If you have a chronic hemolytic condition, adhere to specialist follow‑up and avoid triggers (certain foods, drugs, extreme temperatures).

Emergency Warning Signs

Key Takeaways

Yellowing of the eyes is a visual clue that bilirubin is building up, most often because the liver or biliary system is compromised. While occasional mild jaundice can be benign, persistent scleral icterus warrants medical evaluation to uncover potentially serious conditions such as hepatitis, bile‑duct obstruction, or hemolysis. Prompt diagnosis through blood tests and imaging guides targeted therapy, which can range from antiviral medication to surgical relief of a blockage. Lifestyle measures—especially limiting alcohol, maintaining a healthy weight, and staying vaccinated—are effective preventive strategies.

For personalized advice and evaluation, contact your primary‑care provider or a gastroenterology specialist as soon as you notice unexplained yellowing of the eyes.

---

Sources: Mayo Clinic, CDC, NIH National Institute of Diabetes and Digestive and Kidney Diseases, World Health Organization, Cleveland Clinic, American College of Gastroenterology guidelines.

```